Abacus Global Management Stock Price, News & Analysis

Abacus Global Management (NASDAQ: ABL), a leader in alternative asset management, has filed a lawsuit against Coventry First LLC and its Chairman Alan Buerger for defamation and anticompetitive conduct in Florida's Ninth Circuit Court. The lawsuit alleges that Coventry and Buerger orchestrated a systematic campaign to spread false information about Abacus's valuation practices, culminating in a short report by Morpheus Research on June 4, 2025.

The legal action details how Coventry's campaign led to a 21% drop in Abacus's stock price, erasing over $200 million in market capitalization. Abacus claims Coventry spread misleading information to regulators, auditors, analysts, and investors, particularly regarding Abacus's use of Lapetus Solutions for life expectancy estimates.

Abacus CEO Jay Jackson emphasizes that the company's transparent pricing model has been validated by market transactions, with policies consistently selling to sophisticated investors like KKR at prices exceeding Abacus's valuations. The company is seeking hundreds of millions in damages for harm to its reputation, customer base, and investor relationships.

Abacus Global Management (NASDAQ: ABL) has launched an exchange offer and consent solicitation for its outstanding public and private placement warrants. The company is offering 0.23 shares of common stock for each warrant tendered, with a total offering of up to 4,743,381 shares of common stock in exchange.

The exchange offer will run until July 29, 2025. Concurrently, Abacus is seeking consent to amend the warrant agreement to require remaining warrant holders to exchange their warrants for 0.207 shares of common stock, a 10% reduction from the current offer ratio. Currently, parties representing 25% of public warrants and 94% of private placement warrants have agreed to the exchange.

As of June 30, 2025, Abacus has 97,867,821 shares of common stock outstanding and 20,623,395 total warrants. If all warrant holders participate, the company would issue approximately 4.7 million new shares, increasing the total outstanding shares by about 5% to 102,611,202.

Abacus Global Management (NASDAQ: ABL) has announced plans to conduct an exchange offer and consent solicitation for its outstanding warrants. The company is offering 0.23 shares of common stock for each warrant tendered in the exchange. Additionally, ABL is seeking consent to amend the Warrant Agreement to require remaining warrant holders to exchange their warrants for 0.207 shares of common stock, a 10% lower ratio than the initial offer.

Currently, each warrant allows holders to purchase one common share at $11.50 per share. The amendment would require approval from at least 50% of public warrant holders. The exchange offer will commence following the filing of a Form S-4 registration statement.

Abacus Global Management (NASDAQ: ABL) launched a new corporate commercial campaign at their Investor Day and Longevity Summit at Nasdaq in NYC on June 12th, 2025. The campaign positions Abacus as a leader in longevity-based asset management, featuring CEO Jay Jackson highlighting the company's mission to revolutionize financial planning by incorporating lifespan data. The commercial, now airing nationally, emphasizes Abacus's proprietary longevity data and their unique position in providing longevity-based financial solutions to clients.

Abacus Global Management (NASDAQ: ABL) has strongly refuted recent short seller claims regarding its balance sheet valuation practices. The company provided evidence through an independent third-party actuarial validation by Lewis and Ellis, which confirmed their Q1 2025 life settlement portfolio valuation of $449 million, aligning within 1% of Abacus's stated $446 million valuation. Multiple analysts maintain positive ratings with price targets ranging from $12-$15. The company clarified its dual valuation approach: using life expectancy estimates for consumer transactions while employing market-based valuations for portfolio management. Recent Q2 sales of 226 policies for $141.4 million validated their mark-to-market approach, generating a 1.65% gain over their March 31 valuations. Management, owning 46% of shares, faces a lock-up expiration in July 2025, with anticipated inclusion in Russell 2000 and 3000 indices in August 2025.

Abacus Global Management (NASDAQ: ABL) has announced a new $20 million share repurchase program effective June 5, 2025, extending over 18 months. The announcement comes amid a short attack on the company, with CEO Jay Jackson stating that the current share price is artificially depressed. The company's employees have demonstrated confidence by purchasing over $2 million worth of shares. The repurchase program allows the company to buy shares through various methods including open market transactions and block trades. The timing and value of repurchases will be determined based on factors such as stock price, market conditions, and available liquidity. The program will be funded through cash on hand and future free cash flow. Abacus maintains its 20-year track record of generating positive revenue and plans to pursue legal action against those responsible for the short attack.

Abacus Global Management (NASDAQ: ABL) has issued a strong rebuttal to a short seller's report, defending its 20-year track record in the life insurance policy trading business. The company reported Q1 2025 realized gains of nearly 40% on $126 million deployed capital, with valuations within 2% margin of error from the previous quarter. CEO Jay Jackson emphasized that Abacus's returns and valuations are audited, suggesting the short report was orchestrated by their largest competitor. As the only publicly traded company in its category, Abacus highlighted its high regulatory oversight across multiple states. The company plans to provide a detailed response to the short seller's claims and pursue legal action against those responsible for the allegedly false and misleading attack.

Abacus Global Management (NASDAQ: ABL) has announced the details for its upcoming virtual Abacus Investor Day and Longevity Summit, scheduled for Thursday, June 12th, 2025. The event will run from 9:30 AM ET to 12:45 PM ET and will be accessible via livestream.

This specialized one-day event will focus on integrating lifespan considerations into financial products. The summit will feature presentations on the company's business model, current ABL products, and future outlook. Additionally, leading experts in longevity and lifespan will discuss how human longevity impacts financial planning strategies.

Abacus Global Management (NASDAQ: ABL) reported strong Q1 2025 financial results, with total revenue more than doubling to $44.1 million compared to $21.5 million in Q1 2024. The company achieved GAAP net income of $4.6 million, reversing a $1.3 million loss from the previous year. Adjusted net income grew 158% to $17.3 million, while Adjusted EBITDA doubled to $24.5 million with a 55.6% margin.

Key highlights include $122.8 million in capital inflows to their Longevity Funds and origination capital deployment of $124.9 million. The company's policy portfolio expanded to 753 policies, up from 322 year-over-year. Abacus maintains its 2025 outlook for Adjusted net income between $70-78 million, projecting 51-68% growth compared to 2024.